- Prev Rank61
- LocationHaifa Bay, Israel
- IndustryPharmaceuticals
- SectorHealth Care
- F1000 Rank-
- G500 Rank-
- Current Streak2
Who knew the fight against fungus could be so lucrative? Sales of antifungal drug nystatin/triamcinolone mushroom for this Israeli generic-drug maker.
Looking for leads, investment insights, or competitive intelligence?Get Premium Access
Company Information
| Location | Haifa Bay, Israel |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Current Streak | 2 |
Revenue, Net Income
| Revenue Past Four Quarters | 759 |
| Net Income Past Four Quarters | 360.4 |
Growth Rates & Ranks
| EPS Growth Rank | 44 |
| EPS 3 yr Annual Growth Rate Pct | 60 |
| Revenue Growth Rank | 81 |
| Rev 3 yr Annual Growth Rate | 24 |
| Total Return 3 yr Annual Rate | 89 |
| Total Return Rank | 5 |
| Beat S&P 3 yr Annual Growth Rate? | yes |
| P/E current fiscal year profits (est.) | 17.8 |
